These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 8615855)
1. Validation of the (omega-1)-hydroxylation of lauric acid as an in vitro substrate probe for human liver CYP2E1. Amet Y; Berthou F; Baird S; Dreano Y; Bail JP; Menez JF Biochem Pharmacol; 1995 Nov; 50(11):1775-82. PubMed ID: 8615855 [TBL] [Abstract][Full Text] [Related]
2. Evidence that cytochrome P450 2E1 is involved in the (omega-1)-hydroxylation of lauric acid in rat liver microsomes. Amet Y; Berthou F; Goasduff T; Salaun JP; Le Breton L; Menez JF Biochem Biophys Res Commun; 1994 Sep; 203(2):1168-74. PubMed ID: 8093035 [TBL] [Abstract][Full Text] [Related]
3. Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes. Clarke SE; Baldwin SJ; Bloomer JC; Ayrton AD; Sozio RS; Chenery RJ Chem Res Toxicol; 1994; 7(6):836-42. PubMed ID: 7696540 [TBL] [Abstract][Full Text] [Related]
4. P-450-dependent metabolism of lauric acid in alcoholic liver disease: comparison between rat liver and kidney microsomes. Amet Y; Lucas D; Zhang-Gouillon ZQ; French SW Alcohol Clin Exp Res; 1998 Apr; 22(2):455-62. PubMed ID: 9581653 [TBL] [Abstract][Full Text] [Related]
5. Noninvolvement of CYP2E1 in the (omega-1)-hydroxylation of fatty acids in rat kidney microsomes. Amet Y; Zerilli A; Goasduff T; Dréano Y; Berthou F Biochem Pharmacol; 1997 Oct; 54(8):947-52. PubMed ID: 9354595 [TBL] [Abstract][Full Text] [Related]
6. The regiospecific hydroxylation of lauric acid by rainbow trout (Oncorhynchus mykiss) cytochrome P450s. Buhler DR; Miranda CL; Deinzer ML; Griffin DA; Henderson MC Drug Metab Dispos; 1997 Oct; 25(10):1176-83. PubMed ID: 9321521 [TBL] [Abstract][Full Text] [Related]
7. Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1. Ono S; Hatanaka T; Hotta H; Tsutsui M; Satoh T; Gonzalez FJ Pharmacogenetics; 1995 Jun; 5(3):143-50. PubMed ID: 7550365 [TBL] [Abstract][Full Text] [Related]
8. Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques. Tassaneeyakul W; Veronese ME; Birkett DJ; Gonzalez FJ; Miners JO Biochem Pharmacol; 1993 Dec; 46(11):1975-81. PubMed ID: 8267647 [TBL] [Abstract][Full Text] [Related]
9. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1. Hyland R; Gescher A; Thummel K; Schiller C; Jheeta P; Mynett K; Smith AW; Mráz J Mol Pharmacol; 1992 Feb; 41(2):259-66. PubMed ID: 1538706 [TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization of lauric acid omega-hydroxylation by a CYP4A1/NADPH-cytochrome P450 reductase fusion protein. Chaurasia CS; Alterman MA; Lu P; Hanzlik RP Arch Biochem Biophys; 1995 Feb; 317(1):161-9. PubMed ID: 7872779 [TBL] [Abstract][Full Text] [Related]
11. Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes. Berthou F; Dreano Y; Belloc C; Kangas L; Gautier JC; Beaune P Biochem Pharmacol; 1994 May; 47(10):1883-95. PubMed ID: 8204106 [TBL] [Abstract][Full Text] [Related]
12. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. Eagling VA; Tjia JF; Back DJ Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822 [TBL] [Abstract][Full Text] [Related]
13. Involvement of cytochrome P450 2E1 in the (omega-1)-hydroxylation of oleic acid in human and rat liver microsomes. Adas F; Berthou F; Picart D; Lozac'h P; Beaugé F; Amet Y J Lipid Res; 1998 Jun; 39(6):1210-9. PubMed ID: 9643352 [TBL] [Abstract][Full Text] [Related]
14. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes. Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855 [TBL] [Abstract][Full Text] [Related]
15. Mammalian PC-12 cell genetically engineered for human cytochrome P450 2E1 expression. Mapoles J; Berthou F; Alexander A; Simon F; Ménez JF Eur J Biochem; 1993 Jun; 214(3):735-45. PubMed ID: 8391436 [TBL] [Abstract][Full Text] [Related]
16. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450. Ghosal A; Satoh H; Thomas PE; Bush E; Moore D Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602 [TBL] [Abstract][Full Text] [Related]
17. A novel rat hepatic clofibrate-inducible cytochrome P450 that is not a lauric acid hydroxylase. Swinney DC; Webb AS; Freedman R Biochem Pharmacol; 1991 Nov; 42(12):2341-9. PubMed ID: 1662512 [TBL] [Abstract][Full Text] [Related]
18. Identification of CYP4A11 as the major lauric acid omega-hydroxylase in human liver microsomes. Powell PK; Wolf I; Lasker JM Arch Biochem Biophys; 1996 Nov; 335(1):219-26. PubMed ID: 8914854 [TBL] [Abstract][Full Text] [Related]
19. Omega- and (omega-1)-hydroxylation of arachidonic acid, lauric acid and prostaglandin A1 by multiple forms of cytochrome P-450 purified from rat hepatic microsomes. Tanaka S; Imaoka S; Kusunose E; Kusunose M; Maekawa M; Funae Y Biochim Biophys Acta; 1990 Apr; 1043(2):177-81. PubMed ID: 2317528 [TBL] [Abstract][Full Text] [Related]